The Liver Week 2026

The Liver Week 2026

ABSTRACT

Turning Evidence into New Standards inLiver Disease Care

June 11-13, 2026ICONRAD, Seoul, Korea

SUBMISSION GUIDELINES PRESENTATION GUIDELINES AWARD PROGRAM

Submission Guidelines

AbstractSubmission Deadline

Wednesday, March 4, 2026

Abstract Submission Process

  •  Sign Up

    If you are already signed-up on this website, you can use the account for your abstract submission.

  • Submission and Confirmation

    After your abstract submission, a confirmation letter will be sent to you via e-mail.

  •  My Page

    To review or modify your submitted abstracts, visit 'My Page'.

  • Acceptance
    Notification

    An acceptance notification will be sent to you via e-mail.

Important Notes:

  • Presenting Author: The presenting author must be one of the authors listed in the abstract.
  • Submission by First Author: The abstract submission should be done by the first author.
  • Conference Registration: All presenting authors must register and pay for the conference by Monday, April 27, 2026.
  • Language: Abstracts must be submitted in English.
  • No Withdrawals or Updates: After acceptance notification, abstracts cannot be withdrawn or updated.

Abstract Category

An abstract can be submitted for presentation at the conference in one of the following categories:
Oral Presentation
OR
Poster Exhibition

Guidelines for Abstract Submission

Please adhere to the following formatting guidelines when submitting abstracts for the conference. 

  • Abstract Title: must not exceed 20 words (First letter of each word in uppercase, except for articles, prepositions, and conjunctions).
  • Abstract Text: must not exceed 300 words (excluding the Title, Authors, and Affiliations).
  • An Acceptable Structure of an abstract must consist of the following components:
  • Background/Aim: A statement of the hypothesis or research question.
  • Methods: An explanation of the study design and experimental methods used.
  • Results:
    • A concise summary of the major findings of the experiment or study.
    • Sufficient data must be provided to permit evaluation by the reviewers and public reading the abstract.
    • Statements such as "The data will be discussed" are not acceptable.
  • Conclusion(s): Summary of the overall findings and the importance of the study.
  • Graphics and Tables can be submitted as part of an abstract. The maximum file size of each graphic/tables is 500 KB.
  • Author Names and Affiliations:
    Up to 15 authors and affiliations may be included on each abstract. All authors must have consented to the abstract submission.
    Do not reference institution names, locations, or funding sources in the abstract.
  • Presenting authors are responsible for proofreading before submission. No edits will be allowed in submitted abstracts for typing, spelling, or grammatical errors.

Suggested Topics for Abstract Submission are:

  • HBV, Basic
  • HBV, Clinical
  • HCV, Basic
  • HCV, Clinical
  • Liver Cirrhosis, Portal Hypertension with Cx. Basic
  • Liver Cirrhosis, Portal Hypertension with Cx. Clinical
  • MASLD, Basic
  • MASLD, Clinical
  • Alcohol-Related Liver Disease, Basic
  • Alcohol-Related Liver Disease, Clinical
  • Autoimmune Liver Disease
  • Acute Liver Failure and Drug-Induced Liver Injury
  • Liver Cancer, Basic
  • Liver Cancer, Clinical
  • Liver Surgery
  • Biliary and Pancreatic Surgery
  • Liver Transplantation
  • Others, Medical
  • Others, Surgical

Notification of Acceptance

  • Notification of Acceptance: Presenting authors and corresponding authors will be notified of their acceptance status by April 6th, 2026.
  • Inform Co-Authors: Presenting authors are responsible for informing co-authors of the acceptance.
  • Organizing Committee Rights: The Organizing Committee reserves the right to accept or decline submissions and to select the format of the presentation.

Abstract Modification or Withdrawal

  • Presenting Authors may modify or withdraw the submitted abstract at My Page prior to the submission deadline.
  • Following receiving a notification of acceptance via email, any abstracts cannot be modified or withdrawn.

Questions

  • For questions regarding Abstract Submission, please contact:  Conference Secretariat at abstract@hbni.co.kr.